Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jan 25, 2018
Translation in Brief

Melanoma vs. melanoma

PEDF-presenting exosomes may be able to prevent metastasis of melanoma
BioCentury | Dec 13, 2017
Distillery Therapeutics

Cancer

BioCentury | Nov 16, 2015
Emerging Company Profile

Bridge to POC

How BRIM is bridging a translational science gap in Taiwan
BioCentury | Aug 19, 2010
Distillery Therapeutics

Indication: Cancer

BioCentury | Aug 6, 2009
Targets & Mechanisms

Signaling insulin resistance in obesity

BioCentury | Jul 23, 2009
Distillery Therapeutics

Indication: Various

BioCentury | Mar 2, 2009
Product Development

Wet AMD pipeline

BioCentury | Oct 16, 2008
Distillery Therapeutics

This Week in Therapeutics

BioCentury | Jan 29, 2007
Product Development

Back-of-the-eye pipeline

BioCentury | Jan 29, 2007
Product Development

Optical focus

Items per page:
1 - 10 of 32